Seroprevalence of mumps in an epidemic period in Medellín, Colombia

Vaccine. 2015 Oct 13;33(42):5606-5612. doi: 10.1016/j.vaccine.2015.08.088. Epub 2015 Sep 10.

Abstract

Objective: We related seroprevalence and outbreaks data in order to identify factors that could explain the occurrence of outbreaks despite high vaccination coverage in Medellín Colombia.

Methods: Samples from a population seroprevalence data obtained in 2009 in a random survey were analyzed. IgG levels were determined for mumps using 2 commercial tests of 2119 individuals aged 6-64 years. A comparative analysis was undertaken using age-specific mumps seroprevalence data and information of 98 epidemiological investigations of mumps outbreaks reported in 2009.

Results: Overall, seroprevalence was 91.6% (95% CI=89.3-93.5%). The age-specific seronegativity was 20.3% and 20.6% in age groups 11-15 years and 16-20 years respectively. Individuals aged 6-20 years were the most affected during outbreaks. In individuals born in 2003, a year after the change in the booster schedule from 10 to 5 years, the proportion of unvaccinated individuals (14%) and those who received only one dose of MMR (45%) increased substantially. On average, 23.5 days elapsed between the onset of symptoms in secondary cases and the outbreak investigation.

Conclusion: Potential contributing factors for the occurrence of outbreaks of mumps were the relatively high prevalence of seronegativity among individuals aged 11-20 years, delays in investigation and control of outbreaks, and incomplete vaccination schedules.

Keywords: Colombia; Disease outbreaks; Medellín; Mumps; Seroepidemiological studies.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Antibodies, Viral / blood
  • Child
  • Colombia / epidemiology
  • Disease Outbreaks*
  • Female
  • Humans
  • Immunization Schedule
  • Immunoglobulin G / blood
  • Male
  • Measles-Mumps-Rubella Vaccine / administration & dosage
  • Middle Aged
  • Mumps / epidemiology*
  • Prevalence
  • Seroepidemiologic Studies
  • Vaccination / statistics & numerical data
  • Young Adult

Substances

  • Antibodies, Viral
  • Immunoglobulin G
  • Measles-Mumps-Rubella Vaccine